Premier Alternatives

Mend (Pharmaceuticals and Biotechnology)

New York, NY · Founded 2014 · Privately Held (backing)

Developer of clinical nutritional products designed to assist people in healing and living a quality life. Mend (Pharmaceuticals and Biotechnology) is based in New York, NY and was founded in 2014. Its last reported valuation was $115 million in Feb 2026. It has raised $36.2 million.

Last reported valuation
$115.0M
Oct 2026
Priced at
—
Total raised
$36.2M
Last round
—

Mend (Pharmaceuticals and Biotechnology) key facts

as of Oct 2026
  • Developer of clinical nutritional products designed to assist people in healing and living a quality life.
  • Mend (Pharmaceuticals and Biotechnology) is valued at approximately $115.0M as of Oct 2026 (last reported valuation).
  • It has raised $36.2M; the latest was Later Stage VC ($13.8M) in Feb 2026.
  • Notable investors include Alumni Ventures, S2G Investments, iSelect Fund, The Pay It Forward Company, H/L Ventures — 16 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$115.0M

Mend (Pharmaceuticals and Biotechnology)'s last reported valuation, Feb 2026. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Mend (Pharmaceuticals and Biotechnology) with a free account
  • ·The complete investor list: 16 names
  • ·Watch Mend (Pharmaceuticals and Biotechnology): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Mend (Pharmaceuticals and Biotechnology) funding rounds

No rounds on record

No funding rounds for Mend (Pharmaceuticals and Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Mend (Pharmaceuticals and Biotechnology) valuation

Mend (Pharmaceuticals and Biotechnology)'s last reported valuation was $115 million in Feb 2026. No priced round, secondary trade or fund mark has surfaced since.

Mend (Pharmaceuticals and Biotechnology) investors

16 investors are on record for Mend (Pharmaceuticals and Biotechnology), including Alumni Ventures, S2G Investments, iSelect Fund and The Pay It Forward Company. By type, the record holds 6 venture capital firms and 4 family offices.

About Mend (Pharmaceuticals and Biotechnology)

Developer of clinical nutritional products designed to assist people in healing and living a quality life. The company is focused on researching and developing clinical nutrition and medical food interventions to enhance patient outcomes and is in constant research and development, enabling caregivers to construct useful health outcomes from injury, surgery, or illness for aging and human performance purposes.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2014
Employees
47
Website
mend.me/
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.